Evaluation of cationic nanosystems with melatonin using an eye-related bioavailability prediction model

Chitosan Nanoparticles as New Ocular Drug Delivery Systems: in Vitro Stability, in Vivo Fate, and Cellular Toxicity

Ángela Machado de Campos, Yolanda Diebold, Edison Luis Santana Carvalho et al. · Pharmaceutical Research · 2004 · 404 citations

Nanoparticles, Nanomedicine, Engineering +9

Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention

Olivia Felt · International Journal of Pharmaceutics · 1999 · 357 citations

Precorneal Retention, Ophthalmology, Topical Use +8

The tight junction protein complex undergoes rapid and continuous molecular remodeling at steady state

Le Shen, Christopher R. Weber, Jerrold R. Turner · The Journal of Cell Biology · 2008 · 350 citations · Full text

Novel Hyaluronic Acid-Chitosan Nanoparticles for Ocular Gene Therapy

María de la Fuente, Begon a Seijo, Marı́a José Alonso · Investigative Ophthalmology & Visual Science · 2008 · 283 citations · Full text

Determination of Drug Release Kinetics from Nanoparticles: Overcoming Pitfalls of the Dynamic Dialysis Method

Sweta Modi, Bradley D. Anderson · Molecular Pharmaceutics · 2013 · 281 citations

Nanoparticles, Engineering, Bilayer Permeability +19